Park Place Capital Corp Teva Pharmaceutical Industries LTD Transaction History
Park Place Capital Corp
- $331 Million
- Q4 2024
A detailed history of Park Place Capital Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Park Place Capital Corp holds 683 shares of TEVA stock, worth $14,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
683
Previous 466
46.57%
Holding current value
$14,704
Previous $8,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
629Shares Held
574MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$926 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$780 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$744 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$621 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$571 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $23.9B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...